I apologize for any confusion. The Pfizer-BioNTech COVID-19…

I apologize for any confusion. The Pfizer-BioNTech COVID-19 vaccine, under the brand name Comirnaty, did receive full approval from the FDA on August 23, 2021, for individuals 16 years of age and older. The Emergency Use Authorization (EUA) was granted initially before the full approval. The EUA allowed for the distribution and administration of the vaccine based on the available data on safety and efficacy. The FDA reviews and assesses the data to ensure that vaccines meet the necessary standards for safety and effectiveness. As for the specific details regarding manufacturing and quality standards, I don't have access to that information. It's always a good idea to consult trusted sources for accurate and up-to-date information on vaccines and their regulatory processes.